Associated Papers
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Lavoro A et al.
International Journal of Oncology, 2022
Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.
Wu H et al.
Gene Therapy, 2017
BRCA1 germline mutations may be associated with reduced ovarian reserve.
Wang ET et al.
Fertility and Sterility, 2014
BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia.
Shanmughapriya S et al.
Oncology, 2013
Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.
Krajc M et al.
Bmc Medical Genetics, 2008
Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients.
Lee E et al.
Breast Cancer Research : Bcr, 2008
18284688 (PubMed )
Supplement: bcr1865-S3.doc
Founder mutations in BRCA1 and BRCA2 genes.
Ferla R et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2007
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH et al.
Human Mutation, 2006
Androgen pathway dysregulation in BRCA1-mutated breast tumors.
Berns EM et al.
Breast Cancer Research and Treatment, 2003
Inactivation of BRCA1 and BRCA2 in ovarian cancer.
Hilton JL et al.
Journal of the National Cancer Institute, 2002
Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure.
Spitzer E et al.
International Journal of Cancer, 2000
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
Peelen T et al.
British Journal of Cancer, 2000
Select a paper to view details